Forescout's core offering is the Forescout 4D Platformβ’, a comprehensive cybersecurity solution designed to continuously discover, assess, control, and govern all connected cyber assets, both managed and unmanaged, across the extended enterprise. This includes critical environments like IT, IoT, IoMT (Internet of Medical Things), and OT (Operational Technology) networks.
For the biotech and healthcare sectors, the platform specializes in Medical Device Security, delivering unparalleled insights and control without disrupting clinical operations. Key capabilities include:
- Real-time Asset Intelligence: Agentless discovery and classification of every connected device, including non-traditional medical devices (infusion pumps, heart monitors, X-ray systems, etc.), providing persistent, high-fidelity inventory.
- Comprehensive Risk Assessment: Quantifies cybersecurity risk based on exposure from vulnerabilities, misconfigurations, and operational criticality, using a unique multifactor risk score.
- Dynamic Network Segmentation: Automatically classifies and groups medical assets to design and dynamically enforce Zero Trust-based segmentation policies, protecting ePHI and ensuring HIPAA compliance.
- Automated Threat Response: Facilitates accelerated incident response, threat detection, and automated policy enforcement to contain non-compliant or compromised devices.
The platform is highly valued for its ability to support heterogeneous, multi-vendor network environments and its agentless approach, which is critical for securing sensitive IoMT and OT devices that cannot support traditional agents. It serves mid-sized to large enterprises, government, and financial services, with a proven track record among hundreds of healthcare providers.



